FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2605940892> ?p ?o ?g. }

• W2605940892 endingPage "1373" @default.
• W2605940892 startingPage "1366" @default.
• W2605940892 abstract "The impact of cancer therapies on cardiac disease in the general adult cancer survivor population is largely unknown. Our objective was to evaluate which tyrosine kinase-targeting drugs are associated with greater risk for new-onset heart failure (HF). A nested case–control analysis was conducted within a cohort of 27 992 patients of Clalit Health Services, newly treated with a tyrosine kinase-targeting, and/or chemotherapeutic drug, for a malignant disease, between 1 January 2005 and 31 December 2012. Each new case of HF was matched to up to 30 controls from the cohort on calendar year of cohort entry, age, gender, and duration of follow-up. Main outcome measure was odds ratio (OR) with 95% confidence interval (CI) of new-onset HF. There were 936 incident cases of HF during 71 742 person-years of follow-up. Trastuzumab (OR 1.90, 95% CI 1.46–2.49), cetuximab (OR 1.72, 1.10–2.69), panitumumab (OR 3.01, 1.02–8.85), and sunitinib (OR 3.39, 1.78–6.47) were associated with increased HF risk. Comorbidity independently associated with higher risk in a multivariable conditional regression model was diabetes mellitus, hypertension, chronic renal failure, ischaemic heart disease, valvular heart disease, arrhythmia, and smoking. Trastuzumab, cetuximab, panitumumab, and sunitinib are associated with increased risk for new-onset HF." @default.
• W2605940892 created "2017-04-28" @default.
• W2605940892 creator A5005524023 @default.
• W2605940892 creator A5017022896 @default.
• W2605940892 creator A5028460883 @default.
• W2605940892 creator A5066518394 @default.
• W2605940892 creator A5075459515 @default.
• W2605940892 creator A5091650686 @default.
• W2605940892 date "2017-04-11" @default.
• W2605940892 modified "2023-10-18" @default.
• W2605940892 title "Tyrosine kinase-targeting drugs-associated heart failure" @default.
• W2605940892 cites W1525684755 @default.
• W2605940892 cites W1971423532 @default.
• W2605940892 cites W1983530651 @default.
• W2605940892 cites W1989592289 @default.
• W2605940892 cites W1998990808 @default.
• W2605940892 cites W2008304021 @default.
• W2605940892 cites W2028959752 @default.
• W2605940892 cites W2029542561 @default.
• W2605940892 cites W2036378305 @default.
• W2605940892 cites W2046664900 @default.
• W2605940892 cites W2050144711 @default.
• W2605940892 cites W2050674912 @default.
• W2605940892 cites W2072834954 @default.
• W2605940892 cites W2075213874 @default.
• W2605940892 cites W2078459760 @default.
• W2605940892 cites W2087912692 @default.
• W2605940892 cites W2096065464 @default.
• W2605940892 cites W2097698108 @default.
• W2605940892 cites W2098268167 @default.
• W2605940892 cites W2099359513 @default.
• W2605940892 cites W2100809362 @default.
• W2605940892 cites W2101824720 @default.
• W2605940892 cites W2104599448 @default.
• W2605940892 cites W2108209491 @default.
• W2605940892 cites W2112472340 @default.
• W2605940892 cites W2112845420 @default.
• W2605940892 cites W2118617167 @default.
• W2605940892 cites W2122472092 @default.
• W2605940892 cites W2131058213 @default.
• W2605940892 cites W2133359909 @default.
• W2605940892 cites W2135412778 @default.
• W2605940892 cites W2141469083 @default.
• W2605940892 cites W2144683140 @default.
• W2605940892 cites W2149456801 @default.
• W2605940892 cites W2149773268 @default.
• W2605940892 cites W2150352336 @default.
• W2605940892 cites W2152647863 @default.
• W2605940892 cites W2157262448 @default.
• W2605940892 cites W2159179344 @default.
• W2605940892 cites W2159594706 @default.
• W2605940892 cites W2163773009 @default.
• W2605940892 cites W2164452916 @default.
• W2605940892 cites W2168847627 @default.
• W2605940892 cites W2171112559 @default.
• W2605940892 cites W2209859982 @default.
• W2605940892 cites W2321173821 @default.
• W2605940892 cites W2323326916 @default.
• W2605940892 cites W2497876789 @default.
• W2605940892 cites W2507734941 @default.
• W2605940892 cites W2518330747 @default.
• W2605940892 cites W2530366440 @default.
• W2605940892 cites W2769648988 @default.
• W2605940892 cites W4241933026 @default.
• W2605940892 doi "https://doi.org/10.1038/bjc.2017.88" @default.
• W2605940892 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5482733" @default.
• W2605940892 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28399109" @default.
• W2605940892 hasPublicationYear "2017" @default.
• W2605940892 type Work @default.
• W2605940892 sameAs 2605940892 @default.
• W2605940892 citedByCount "23" @default.
• W2605940892 countsByYear W26059408922017 @default.
• W2605940892 countsByYear W26059408922018 @default.
• W2605940892 countsByYear W26059408922019 @default.
• W2605940892 countsByYear W26059408922020 @default.
• W2605940892 countsByYear W26059408922021 @default.
• W2605940892 countsByYear W26059408922022 @default.
• W2605940892 countsByYear W26059408922023 @default.
• W2605940892 crossrefType "journal-article" @default.
• W2605940892 hasAuthorship W2605940892A5005524023 @default.
• W2605940892 hasAuthorship W2605940892A5017022896 @default.
• W2605940892 hasAuthorship W2605940892A5028460883 @default.
• W2605940892 hasAuthorship W2605940892A5066518394 @default.
• W2605940892 hasAuthorship W2605940892A5075459515 @default.
• W2605940892 hasAuthorship W2605940892A5091650686 @default.
• W2605940892 hasBestOaLocation W26059408921 @default.
• W2605940892 hasConcept C121608353 @default.
• W2605940892 hasConcept C126322002 @default.
• W2605940892 hasConcept C143998085 @default.
• W2605940892 hasConcept C156957248 @default.
• W2605940892 hasConcept C207103383 @default.
• W2605940892 hasConcept C2778198053 @default.
• W2605940892 hasConcept C2779159551 @default.
• W2605940892 hasConcept C2779490328 @default.
• W2605940892 hasConcept C2779998722 @default.
• W2605940892 hasConcept C2908647359 @default.
• W2605940892 hasConcept C44249647 @default.
• W2605940892 hasConcept C526805850 @default.

• next